| Literature DB >> 32669023 |
Lin Chen1,2, Zhiliang Wei1,2, Kannie Wy Chan2,3, Yuguo Li1,2, Kapil Suchal4, Sheng Bi4, Jianpan Huang3, Xiang Xu1,2, Philip C Wong4,5, Hanzhang Lu1,2, Peter Cm van Zijl1,2, Tong Li4, Jiadi Xu1,2.
Abstract
In this study, we applied on-resonance variable delay multiple pulse (onVDMP) MRI to study D-glucose uptake in a mouse model of Alzheimer's disease (AD) tauopathy and demonstrated its feasibility in discriminating AD mice from wild-type mice. The D-glucose uptake in the cortex of AD mice (1.70 ± 1.33%) was significantly reduced compared to that of wild-type mice (5.42 ± 0.70%, p = 0.0051). Also, a slower D-glucose uptake rate was found in the cerebrospinal fluid (CSF) of AD mice (0.08 ± 0.01 min-1) compared to their wild-type counterpart (0.56 ± 0.1 min-1, p < 0.001), which suggests the presence of an impaired glucose transporter on both blood-brain and blood-CSF barriers of these AD mice. Clearance of D-glucose was observed in the CSF of wild-type mice but not AD mice, which suggests dysfunction of the glymphatic system in the AD mice. The results in this study indicate that onVDMP MRI could be a cost-effective and widely available method for simultaneously evaluating glucose transporter and glymphatic function of AD. This study also suggests that tau protein affects the D-glucose uptake and glymphatic impairment in AD at a time point preceding neurofibrillary tangle pathology.Entities:
Keywords: Alzheimer’s diseases; Glucose uptake; chemical exchange saturation transfer; dynamic glucose enhanced; on-resonance variable delay multiple pulse; tau pathology
Year: 2020 PMID: 32669023 PMCID: PMC8054725 DOI: 10.1177/0271678X20941264
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200